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Abstract
Background: Previous reports showed that mast cells can typically be found in the peritumoral
stroma of cervix carcinomas as well as in many other cancers. Both histamine and TNF-α are
potent preformed mast cell mediators and they can act simultaneously after release from mast cells.
Thus, the effect of TNF-α and histamine on cervical carcinoma cell lines was studied.
Methods and results: TNF-α alone induced slight growth inhibition and cell cycle arrest at G0/
G1 phase in SiHa cells, but increased their migration. Histamine alone had no effect on cells. In
addition, TNF-α and histamine in combination showed no additional effect over that by TNF-α
alone, although SiHa cells were even pretreated with a protein synthesis inhibitor. Furthermore,
TNF-α-sensitive ME-180 carcinoma cells were also resistant to the combination effect of TNF-α
and histamine. In comparison, TNF-α or histamine alone induced growth inhibition in a non-
cytolytic manner in normal keratinocytes, an effect that was further enhanced to cell cytolysis when
both mediators acted in combination. Keratinocytes displayed strong TNF receptor (TNFR) I and
II immunoreactivity, whereas SiHa and ME-180 cells did not. Furthermore, cervix carcinoma
specimens revealed TNF-α immunoreactivity in peritumoral cells and carcinoma cells. However,
the immunoreactivity of both TNFRs was less intense in carcinoma cells than that in epithelial cells
in cervical specimens with non-specific inflammatory changes.
Conclusion: SiHa and ME-180 cells are resistant to the cytolytic effect of TNF-α and histamine
whereas normal keratinocytes undergo cytolysis, possibly due to the smaller amount of TNFRs in
SiHa and ME-180 cells. In the cervix carcinoma, the malignant cells may resist this endogenous
cytolytic action and TNF-α could even enhance carcinoma cell migration.
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Background
The most common form of cervical cancers of the uterus
is squamous cell carcinoma (SCC), but the incidence of
adenocarcinomas has been rising during the past few dec-
ades [1]. Even though virtually all SCCs and the over-
whelming majority of adenocarcinomas are positive for
human papilloma viruses (HPV) and HPV is the main
causal factor for the development of cervical cancer [2].
The essential processes, that play a key role in the develop-
ment of cervical squamous cell carcinoma, include regula-
tion of cell apoptosis and proliferation, angiogenesis and
immune surveillance. Inhibition of apoptosis, loss of cell
cycle control, and stimulation of proliferation of an HPV-
infected cell are essential features in the carcinoma growth
[2].
Tumor necrosis factor-α (TNF-α) plays an important role
during the inflammatory response and appears to be a key
cytokine involved in antiviral, antibacterial and antipara-
sitic host defense mechanisms. The antitumoral effects of
TNF-α have been shown to be the result of three different
biological mechanisms: primarily hemorrhagic necrosis
by TNF-α action on tumor endothelium, TNF-α immu-
nomodulatory activity on immune effector cells, and a
direct TNF-α mediated cytotoxic effect on tumor cells.
However, paradoxically to its name and anticipated bio-
logical behaviour TNF-α can also have different effects
which may promote tumor growth and metastasis [3,4].
The mechanisms for possible promotion of cervix carci-
noma growth by TNF-α may include the stimulation of
HPV-infected carcinoma cell growth in culture medium
depleted from growth factors [5], induction of HPV-16
E6/E7 expression [6], and/or stimulation of epithelial
tumor cell motility [7]. In addition, cervix carcinoma cells
can be resistant to the cytolytic action of TNF-α or TNF-β
and an additional stressor, such as treatment with a pro-
tein synthesis inhibitor or radiation, is needed for TNF-
induced cytolysis [8-10].
Cancer cells are surrounded by stroma that contains
numerous different cell types including the cells of the
immune system. Therefore, numerous inflammatory
mediators are acting simultaneously on cancer cells. Pre-
viously, an increase in cell lysis has been observed after
the treatment of gynecologic tumor cell lines with inter-
feron-γ and TNF-α [11,12]. A similar antiproliferative syn-
ergism has also been observed when treating gynecologic
tumor cell lines with delta 12-prostaglandin J2 and TNF
[13]. Also histamine has been reported to function syner-
gistically with TNF-α when inducing intercellular adhe-
sion molecule-1 expression in normal keratinocytes [14].
In addition, heparin can augment the growth inhibition
of keratinocytes induced by TNF-α [15]. Histamine has
been found to function synergistically also with inter-
leukin-2 and this combination of mediators is under clin-
ical trials in the treatment of different malignant diseases
[16-18]. Furthermore, a cross-talk between histamine and
interleukin-6 has been suggested in the regulation of
melanoma cell growth [19]. Histamine, as well as TNF-α,
has been found to function synergistically with chemo-
therapeutic drugs in the treatment of tumors and they
appear to primarily target the tumor-associated vascula-
ture [20]. Histamine and heparin are the essential and
potent mediators residing in mast cell secretory granules,
cells which are also a predominant source for TNF-α in
epithelial cancer [21]. Also, mast cells have been found to
be abundantly present in invasive carcinomas of the uter-
ine cervix [22]. However, in addition to mast cells also
cancer cells themselves can produce both histamine
[23,24] and TNF-α [25-27].
Previous studies suggest that TNF-α may be able to act
synergistically with histamine in the regulation of growth
of carcinoma cells and keratinocytes, but functional evi-
dence to support this hypothesis is very sparse. Both his-
tamine and TNF-_ have previously been tested in clinical
trials to treat cancer patients. Therefore, the well-estab-
lished and HPV-16 positive SiHa carcinoma cell line
derived from SCC of the uterine cervix was treated with
TNF-α and/or histamine and subsequently the growth,
viability, cell cycle, migration and invasion of SiHa cells
were measured. Another carcinoma cell line, ME-180, was
also used. In addition, the effect of TNF-α and histamine
on the growth of normal keratinocytes was studied for
comparison. Further, we measured and compared the
expression of TNF receptors I and II in these cells and cer-
vix carcinoma specimens. The results indicate that the
combined action of TNF-α and histamine has profound
cytolytic effects on normal keratinocytes but SiHa and
ME-180 cells are resistant to these mediators suggesting
that these malignant cells can escape from the control
mechanism of TNF-α and histamine.
Methods
Chemicals
Minimum essential medium (MEM), McCoy's 5a
medium, Keratinocyte-SFM medium, fetal calf serum
(FCS), sodium pyruvate, sodium bicarbonate, non-essen-
tial amino acids and supplements for Keratinocyte-SFM
medium were purchased from GIBCO™ (Life Technolo-
gies Ltd, Paisley, UK). Bovine serum albumin (BSA), 3-
(4,5-dimetylthiazol-2-yl)-2,5-diphenyl tetrazolium bro-
mide (MTT), emetine and diaminobensidine (DAB) were
purchased from Sigma-Aldrich (St. Louis, MO, USA).
Recombinant human TNF-α, goat anti-human TNFRI/
TNFRSF1A polyclonal antibody, and goat anti-human
TNFRII/TNFRSF1B (TNF-BPII) polyclonal antibody were
from R&D Systems Europe Ltd (Oxon, UK) and rabbit
polyclonal antibody against human TNF-α from HyCult
biotechnology b.v. (Uden, The Netherlands). HoechstBMC Cancer 2008, 8:46 http://www.biomedcentral.com/1471-2407/8/46
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33258 (bis-benzimide) and propidium iodide are prod-
ucts of Molecular Probes Europe BV (Leiden, The Nether-
lands). Histamine diphosphate monohydrate was
purchased from Fluka BioChemica (Buchs, Germany),
Dulbecco's phosphate-buffered saline (PBS) and penicil-
lin-streptomycin solution from Cambrex (Bio Science
Verviers, Belgium), Vectastain ABC-Elite Goat IgG kit Vec-
tor PK-6103 from Vector Laboratories, INC. (Burlingame,
CA, U.S.A.), NiCl2 and dimethylsulfoxide (DMSO) from
Merck-Schuchardt (Munich, Germany). BD BioCoat™
Matrigel™ Invasion Chambers and control inserts were
purchased from BD Bioscience (BD Bioscience Discovery
Labware, Bedford, USA).
Cultivation of normal keratinocytes and cervical squamous 
carcinoma cell lines SiHa and ME-180
Proliferating pure keratinocytes from human foreskin
specimens were cultured under standard conditions
(humidified atmosphere at 5% CO2, and 37°C) in Kerat-
inocyte-SFM serum-free medium supplemented with epi-
dermal growth factor (EGF), bovine pituitary extract
(BPE), 100 U/ml penicillin and 100 μg/ml streptomycin
[15,28]. The cells were passaged every 3–4 days and cells
from passages 3rd to 8th with a viability of over 90% were
used as measured by trypan blue exclusion method.
The SiHa carcinoma cell line derived from a 55-year-old
japanese patient with grade II squamous cell carcinoma
and the ME-180 cell line derived from a 66-year-old cau-
casian patient with a highly invasive squamous cell carci-
noma in the uterine cervix were obtained from the
American Type Culture Collection (Rockville, MD., USA).
SiHa cells were cultured in minimum essential medium
(MEM) supplemented with 10% fetal calf serum (FCS),
0.1 mM non-essential amino acids, 1.0 mM sodium pyru-
vate, 1.5 g/L sodium bicarbonate, 100 U/ml penicillin and
100 μg/ml streptomycin at 5% CO2 and 37°C. ME-180
cells were cultured in McCoy's 5a medium supplemented
with 10% FCS. The SiHa cell line is reported to contain an
integrated HPV-16 in the genome (1 to 2 copies per cell).
ME-180 cells contain HPV DNA with greater homology to
HPV-39 than HPV-18. The cells were passaged every 2–3
days. In every experiment, cells with a viability of over
90% were used.
Fluorometric DNA Assay for Cell Growth
The cell growth by DNA content was determined using a
fluorometric DNA assay as described previously [15,28].
Keratinocytes, ME-180 and SiHa cells were seeded in wells
of a 24-well plate (Nunc, Roskilde, Denmark) with a den-
sity of about 15,000 cells/well (7,500 cells/cm2) using
complete Keratinocyte-SFM medium for keratinocytes,
complete McCoy's 5a medium for ME-180 cells, and com-
plete MEM for SiHa cells. The optimal cell density was
confirmed by using a variable number of cells. Next day,
the medium was replaced with a fresh one (complete or
incomplete Keratinocyte-SFM, McCoy's 5a medium or
MEM). The adhered cells were treated with various con-
centrations of modulating agents or diluent control (PBS
or PBS together with 1% bovine serum albumin) for 2–3
days and then a solution consisting of 0.04% sodium
dodecyl sulphate and 8 M urea was added into the wells
at 37°C for 1 h to dissolve the DNA of cells. Thereafter,
1.0 μg/ml of Hoechst 33258 was added and the fluores-
cence of the solution was measured using Spectra Fluor
reader (Q-Lab Pty Ltd, Eagle Farm, Australia). The cultures
and analyses were performed using quadruplicate wells
and each experiment was performed at least four times.
Determination of cytotoxicity and cell viability
Cell viability and cytotoxicity effects of different modulat-
ing agents were measured by the MTT assay as described
[15,28]. Keratinocytes, ME-180 cells or SiHa cells were
seeded in wells of a 96-microwell plate with a density of
about 4,000 cells/well using complete Keratinocyte-SFM,
McCoy's 5a medium or MEM, respectively. Next day, the
medium was replaced with a fresh one (complete or
incomplete Keratinocyte-SFM, McCoy's 5a medium or
MEM). The adhered cells were treated with various con-
centrations of modulating agents for 6–8 h and then 0.33
mg/ml MTT in incomplete Keratinocyte-SFM was added
into the wells at 37°C and 5% CO2 for 2 h. Thereafter, the
MTT solution was removed and the formed intracellular
dye was solubilized by incubating with DMSO for 15–20
min. The absorbance of the solution was measured at 550
nm using a micro-ELISA reader (SLT-Labinstruments
GmbH, Salzburg, Austria). The cultures and analyses were
performed using eight parallel wells and each experiment
was performed at least four times.
Determination of Cell Cycle
SiHa cells were seeded in 6-well plates using complete
MEM medium. On the following day, the medium was
changed to complete or incomplete MEM and histamine
and/or TNF-α were added to the medium for 24 h. There-
after, the conditioned medium containing possible
detached cells was collected to a test tube. The attached
SiHa cells were released by incubating in trypsin-EDTA for
up to 10 min. After inactivating of trypsin with 10% FCS,
the cell suspension was combined with spontaneously
detached cells. The final SiHa cell suspension was centri-
fuged and washed with D-PBS. For fixation, the cells were
suspended in 0.5 ml of cold D-PBS and the cells were
added cautiously, drop by drop, to 5 ml of ice-cold 70%
ethanol using continuous mix of the solution as described
earlier [15]. After a minimum fixation for 1 day, the cells
were centrifuged and suspended in D-PBS, treated with
0.15 mg/ml RNAse at 50°C for 1 h, and incubated in 16
μg/ml propidium iodide at 37°C for 2 h. Finally, the cellsBMC Cancer 2008, 8:46 http://www.biomedcentral.com/1471-2407/8/46
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were analyzed using FACScan (BD Biosciences, USA) flow
cytometer. The experiment was performed 3 times.
Staining of TNF receptor I and II in keratinocytes and SiHa 
SCC cells
To study whether SiHa and ME-180 cells and normal
keratinocytes are immunopositive for TNF receptor I and
II, goat polyclonal anti-human TNFR I and TNFR II anti-
bodies were used in immunocytochemistry [21]. First,
keratinocytes, SiHa or ME-180 cells were seeded into the
wells of a 4-well chamber slide (Nunc Lab-Tek™) in the
presence of complete Keratinocyte-SFM, MEM or McCoy's
5a medium, respectively. After 2 or 3 days, the culture was
stopped by removing the medium followed by washing
the cells with PBS and fixing them in cold acetone for
10–15 min. Finally, the cells were stained immunocyto-
chemically using Vectastain Elite ABC kit for visualizing
the bound antibodies. The number of keratinocytes, SiHa
or ME-180 cells positive for TNFRI and II were counted.
Determination of keratinocyte growth and migration 
under high-calcium conditions
The growth and migration assay of normal human kerati-
nocytes under high-calcium conditions has been
described previously [15,28]. Briefly, metallic cylinders
were placed (6 mm inner diameter) on the bottom of each
well of an uncoated 6-well plate (Falcon, Becton Dickin-
son, Plymouth, UK). Before addition of cells, the wells
and cylinders were equilibrated in 5 ml of complete Kerat-
inocyte-SFM®  medium at 37°C and 5% CO2. Subse-
quently, about 30,000 keratinocytes, suspended in the
same medium, were added cautiously into each cylinder.
The cells were allowed to adhere onto the plastic surface
overnight and practically complete confluence of kerati-
nocytes was reached. After adherence of cells, the metallic
cylinders were removed and Keratinocyte-SFM®  was
changed to 5 ml of DMEM, 10% FCS, 100 U/ml penicillin
and 100 μg/ml streptomycin, a medium which creates
high-calcium conditions. Under these conditions, monol-
ayer proliferating keratinocytes begin to differentiate and
form a multilayer epithelium. After equilibration for 1–2
h, histamine and/or TNF-α were added in varying combi-
nations and concentrations as described in Results. The
medium and agents were changed every 2–3 days until the
epithelium border almost reached the wall of the well.
Thereafter, the medium was removed and 4% formalde-
hyde was added to the wells overnight for fixing the epi-
thelium. Finally, the epithelium was stained with Mayer's
hematoxylin overnight.
Determination of SiHa cell migration and invasion by the 
in vitro transwell assay
BD Biocoat™ Matrigel™ Invasion chambers and control
chambers (BD Biosciences Europe, Erembodegem, Bel-
gium) for 24-well plates were used to study the effect of
histamine and TNF-α on the migration and invasion of
SiHa cells. For this, 2.5 × 104 SiHa cells were seeded into
the transwells using incomplete DMEM. The lower well
contained complete DMEM. After adherence of the cells at
37°C and 5% CO2 for 1 hour, histamine (0.1 or 1 mM) or
TNF-α (10 or 50 ng/ml) alone or both in combination
were added to the serum-free DMEM medium in the
upper transwell chamber. The plates were kept at 37°C
and 5% CO2 for 24 hours and thereafter the non-migrat-
ing and non-invading cells were removed from the upper
surface of the membrane by "scrubbing". The cells on the
lower surface of the membrane were stained with hema-
toxylin and counted under the microscope at 200× mag-
nification using an ocular grid.
Immunohistochemical staining method for TNF-α, TNFR I 
and II in uterine cervix specimens
Immunohistochemical staining for TNF-α and TNF recep-
tors I and II [21] was performed on 4-μm-thick sections
from formalin-fixed and paraffin-embedded tissue speci-
mens from the uterine cervix collected and used anony-
mously from the archives of diagnostic specimens of
Department of Clinical Pathology, Kuopio University
Hospital. In order to stain TNF-α, the primary antibody
was a rabbit polyclonal anti-human-TNF-α antibody (25
μg/ml). TNF receptors I and II were stained using goat pol-
yclonal antibodies at the concentrations of 15 μg/ml and
10 μg/ml, respectively. The bound antibodies were visual-
ized using the Vectastain Elite ABC kit (Vector Laborato-
ries). As controls for cervix carcinoma specimens, sections
from 10 uterine cervix specimens with nonspecific inflam-
matory changes were used. These diagnostic biopsies had
been taken either during the routine Papanicolaou test or
during surgery. These specimens were known to have non-
specific abundant inflammatory lymphocyte infiltrates
based on the histopathologic examination. None of the
controls were found to have alterations due to HPV infec-
tion. The diagnostic carcinoma biopsies used in the study
were from 8 patients with squamous cell carcinoma in the
uterine cervix verified in the histopathologic examination.
Due to the large number of positive cells in cancer speci-
mens, a scoring system was designed:
The scoring for TNF-α: "++" denotes numerous positive
cell-groups showing strong staining; "+" denotes only
moderate staining, mainly negative; "-" denotes that the
cells are clearly negative.
The scoring for TNFR's: "++" – denotes numerous positive
cell-groups (membrane staining for TNFRI and immuno-
positive cytoplasmic granules for TNFRII); "+" – denotes
many weakly positive areas for TNFRI and few positive
areas for TNFRII; "-" – denotes the cells are mostly nega-
tive but some weakly positive groups of cells are detected.BMC Cancer 2008, 8:46 http://www.biomedcentral.com/1471-2407/8/46
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Statistical Analysis
All data are expressed as the mean ± standard deviation
(SD) or standard error (SE). For comparisons of the
means, Student's t-test for paired samples was performed
to test statistical significance (p < 0.05). Microsoft Excel
software (Microsoft Company, Redmond, Washington,
USA) was used in all analyses.
Results
TNF-α had a weak inhibitory effect but histamine had no 
effect on the DNA content of SiHa cells
Histamine alone (0.1 or 1.0 mM) had no marked effect on
the DNA content of SiHa cells after cultivation in com-
plete medium (Fig. 1). In incomplete medium, only slight
but statistically non-significant inhibition was observed at
both histamine concentrations. Nevertheless, the results
did not reveal any stimulatory effect of histamine on SiHa
cell growth.
TNF-α alone decreased slightly in a dose-dependent man-
ner for up to 25% the DNA content of SiHa cells when
they were cultured in incomplete medium (Fig. 2). Ten
ng/ml TNF-α produced maximal inhibitory effect. In com-
plete medium, the inhibition was not as apparent as in
incomplete medium. The combination of TNF-α and histamine reduced in a 
cumulative manner the DNA content of normal 
keratinocytes but not that of SiHa and ME-180 cells
Histamine (0.1 and 1 mM) and/or TNF-α (10 and 50 ng/
ml) were added alone or in combination to the cell cul-
tures. Normal keratinocytes were compared to SiHa and
ME-180 cells. Significant growth inhibition was found
when keratinocytes were grown with histamine (1 mM) or
TNF-α (10 or 50 ng/ml) (Fig. 3). Furthermore, when his-
tamine and TNF-α were used in combination, the growth
inhibitory effect on keratinocytes was found to be cumu-
lative in both complete and incomplete Keratinocyte-SFM
medium (Fig. 3).
In contrast to normal keratinocytes, histamine alone did
not show any effect and TNF-α inhibited only slightly the
growth of SiHa cells, especially in incomplete medium
(Fig. 4a, b). Furthermore, of interest is the finding that the
combination of histamine and TNF-α did not produce
any additional inhibitory effect over that by TNF-α alone.
In order to clarify whether the ME-180 cell line known to
be sensitive to TNF-α can respond further to the combina-
tion of TNF-α and histamine, these cells were cultured
with these agents. As demonstrated in Fig. 4c, TNF-α alone
inhibited significantly the growth of ME-180 cells but 1
mM histamine did not. However, the combination of
TNF-α and histamine did not result in any further increase
in growth inhibition.
The effect of TNF-α on the DNA content of SiHa cells Figure 2
The effect of TNF-α on the DNA content of SiHa cells. The 
cells were grown in incomplete and complete MEM and 
treated with indicated concentrations of TNF-α. The data 
are expressed as the percentage of the fluorescence in the 
control wells. Each bar represents the mean of individual 
quadruplicate cultures ± SE (n = 4). "*" denotes p < 0.05 
when compared with the control values.
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The effect of histamine on the DNA content of SiHa cells Figure 1
The effect of histamine on the DNA content of SiHa cells. 
The cells were grown in incomplete or complete MEM and 
treated with indicated concentrations of histamine. The data 
are expressed as the percentage of the fluorescence in the 
control wells. Each bar represents the mean of individual 
quadruplicate cultures ± SE (n = 4). "*" denotes p < 0.05 
when compared with the control values.
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The combination of histamine and TNF-α was cytotoxic 
against keratinocytes but not against cervical squamous 
carcinoma cells
The MTT assay was used to clarify whether histamine (0.1
and 1 mM) and/or TNF-α (10 and 50 ng/ml) had cyto-
toxic effects on SiHa, ME-180 cells and keratinocytes. Sig-
nificant cytotoxicity was observed when keratinocytes
were treated with the combination of 0.1 or 1 mM hista-
mine and 10 or 50 ng/ml TNF-α in incomplete and com-
plete medium (Fig. 5a). In addition, keratinocytes were
treated first with either 0.5 mM histamine or 10 ng/ml
TNF-α in complete medium for 1 day followed by replac-
ing with a new medium and addition of increasing con-
centration of TNF-α (0, 1, 10 and 50 ng/ml) or histamine
(0, 0.05, 0.5 and 1.0 mM), respectively, for another day.
Consequently a similar cytotoxic effect in a dose-depend-
ent manner could be seen in both culture systems, maxi-
mally at 10 ng/ml TNF-α or 0.5 mM histamine (not
shown) indicating that a simultaneous presence of hista-
mine and TNF-α is not required for cytotoxicity.
In contrast to normal keratinocytes neither histamine nor
TNF-α, or both in combination, could induce any marked
cytotoxic effect on SiHa or ME-180 cells in complete and
incomplete medium (Fig. 5b, c). Previously, the treatment
of SiHa cells with the protein synthesis inhibitor emetine
has been found to render the cells susceptible to the cyto-
toxic effects of TNF-α [8]. Therefore, emetine was also
tested in this study to find out whether SiHa cells undergo
cytolysis after treatment with emetine and subsequently
with histamine and TNF-α. As demonstrated in Figure 6,
the pretreatment of cells with 10 μM emetine for 18 hours
resulted in an increase in the cytotoxicity by TNF-α alone.
Also histamine appeared to be weakly cytotoxic. However,
the combination of histamine and TNF-α did not show
any increase in cytotoxicity when compared to TNF-α
alone.
The effect of histamine and/or TNF-α on the DNA content  of SiHa and ME-180 cells Figure 4
The effect of histamine and/or TNF-α on the DNA content 
of SiHa and ME-180 cells. SiHa cells were cultured with 0.1 
mM histamine and/or TNF-α (a) or with 1 mM histamine 
and/or TNF-α (b) using incomplete or complete MEM. ME-
180 cells were cultured with 1 mM histamine and/or TNF-α 
(c) using incomplete or complete McCoy's 5a medium. The 
results are expressed as the percentage of the fluorescence 
in the control wells. Each bar represents the mean of four 
individual quadruplicate cultures ± SE. "*" denotes p < 0.05 
when compared with the control values.
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The effect of histamine (1 mM) and/or TNF-α (10 and 50 ng/ ml) on the DNA content of normal keratinocytes Figure 3
The effect of histamine (1 mM) and/or TNF-α (10 and 50 ng/
ml) on the DNA content of normal keratinocytes. The cells 
were cultivated in incomplete or complete Keratinocyte-SFM 
medium and treated with indicated concentrations of hista-
mine and/or TNF-α. The results are expressed as the per-
centage of the fluorescence in the control wells. Each bar 
represents the mean of four individual quadruplicate cultures 
± SE. "*" denotes p < 0.05 when compared with the control 
values.
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The cytotoxic effect of histamine and/or TNF-α on keratinocytes (a), SiHa cells (b) and ME-180 cells (c) Figure 5
The cytotoxic effect of histamine and/or TNF-α on keratinocytes (a), SiHa cells (b) and ME-180 cells (c). The cells were culti-
vated in incomplete or complete medium and treated with indicated concentrations of histamine and/or TNF-α. The results 
are expressed as the percentage of the absorbance in the control wells. Each bar represents the mean of four individual cul-
tures ± SE. "*" denotes p < 0.05 when compared with the control values.
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The growth inhibition of keratinocyte epithelium is 
increased by the simultaneous action of TNF-α and 
histamine
The growth inhibition of keratinocytes induced by TNF-α
and histamine was also confirmed under high-calcium
conditions since carcinoma cells were also cultured in
high-calcium medium. Histamine (0.1 and 1 mM) and
TNF-α (10 and 50 ng/ml) were added into the wells of 6-
well plates. As illustrated in Figure 7, both histamine and
TNF-α inhibited the growth and migration of keratinocyte
epithelium in high-calcium medium. Furthermore, the
growth inhibition was increased when both agents were
present simultaneously in the culture.
TNF-α induced slight cell cycle arrest at G0/G1 in SiHa 
cells but the combination of histamine and TNF-α had no 
additional effect
In order to find out whether TNF-α (10 or 50 ng/ml), his-
tamine (0.1 or 1 mM) or both in combination can modu-
late cell cycle or induce apoptotic cell death (subdiploid
events in the cell cycle analysis), SiHa cells were cultured
with these mediators for 1 day using both incomplete and
complete medium. The adhered and detached cells were
combined and analyzed by flow cytometry after propid-
ium iodide staining. In three independent experiments
with essentially similar results TNF-α at 10 and 50 ng/ml,
histamine at 0.1 and 1 mM and the combination of those
had no marked effect on the cell cycle in incomplete and
complete medium, though TNF-α alone slightly induced
cell cycle arrest at G0/G1 phase especially in incomplete
medium. Neither histamine nor TNF-α or both in combi-
nation could induce apoptotic events above the control
level (3.9% in incomplete and 0.9% in complete
medium).
TNF-α stimulated SiHa cell migration but the combination 
of histamine and TNF-α had no additional effect
In three independent assays, histamine and TNF-α alone
or in combination were tested to find out whether they
could influence the migration and invasion of SiHa cells
in the transwell assay. When histamine alone (0.1 or 1
mM) was added to the transwell, no stimulatory or inhib-
itory effect on SiHa cell migration could be observed.
Instead, a significant increase in the cell migration was
found when the cells were treated with TNF-α. However,
the combination of histamine (0.1 or 1 mM) and TNF-α
(10 or 50 ng/ml) could not induce any additional effect
over that by TNF-α alone (Fig. 8).
The effect of histamine and TNF-α alone or in combina-
tion on SiHa cell invasion was studied by using the
Matrigel transwell assay. However, no significant changes
took place when histamine, TNF-α or the combination of
histamine and TNF-α where tested using the same media-
tor concentrations as in the migration assay, though the
variation between experiments was marked. The ratio of
The effect of histamine and/or TNF-α on the growth of  keratinocyte epithelium in a representative 3-day culture by  using 10% fetal calf serum and DMEM as the culture medium Figure 7
The effect of histamine and/or TNF-α on the growth of 
keratinocyte epithelium in a representative 3-day culture by 
using 10% fetal calf serum and DMEM as the culture medium. 
The following agents were added to the wells: well 1, diluent 
control; well 2, 0.1 mM histamine; well 3, 10 ng mL-1 TNF-α; 
well 4, 50 ng mL-1 TNF-α; well 5, 0.1 mM histamine + 10 ng 
mL-1 TNF-α; well 6, 0.1 mM histamine + 50 ng mL-1 TNF-α. 
Histamine (0.1 mM) or TNF-α (10 or 50 ng/ml) alone inhibits 
the growth of epithelium and the growth-inhibitory effect is 
increased when both agents are added to the same well.
The effect of histamine and/or TNF-α on SiHa cells with and  without inhibition of protein synthesis Figure 6
The effect of histamine and/or TNF-α on SiHa cells with and 
without inhibition of protein synthesis. The cells were pre-
treated with emetine and then cultivated and treated with 
indicated concentrations of histamine and/or TNF-α. The 
results are expressed as the percentage of the absorbance in 
the control wells. Each bar represents the mean of three 
individual cultures ± SD. "*" denotes p < 0.05 when com-
pared with the control values.
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the cell number of invaded cells to that of migrated cells
in the control wells was 14.3 ± 4.9%.
Normal keratinocytes were strongly immunopositive for 
TNFR I and II whereas SiHa and ME-180 cells were not
Chamber slides were used to cultivate SiHa and ME-180
cells and normal keratinocytes for the immunocytochem-
ical staining of TNFRI and II. Three individual cultures
were performed. In the case of keratinocyte culture, 52%
and 36% of the keratinocytes showed immunoreactivity
for TNFR I and TNFR II (Fig. 9), respectively. In contrast,
SiHa cells displayed only weak immunopositivity and less
then 1% of SiHa cells were found to be clearly immunop-
ositive for TNFR I and II when over 1,000 cells were
counted (Fig. 10). Similarly to SiHa cells, also ME-180
cells stained far less intensely to both TNFRs than kerati-
nocytes (not shown).
Numerous TNF-α positive cells in the cervix carcinoma
TNF-α expression in 8 cervix carcinoma samples was sem-
iquantitatively analyzed and compared to that in 10 con-
trol samples with nonspecific inflammatory changes. The
results are expressed using a scoring system, both in the
tumor and peritumoral stroma of carcinoma samples as
well as in the upper subepithelial stroma and epithelium
of control samples. Within the immunopositive cells,
staining was predominantly localized to the cytoplasm in
a granular fashion. Distribution of staining within the epi-
thelium was remarkably similar and consistent in control
samples: 7 specimens showed clear positivity and 3 sam-
ples very strong positivity in the basal and suprabasal epi-
thelial cells (Fig. 11a). In cervix carcinoma samples, tumor
cells and peritumoral stroma were found to be positive in
7 out of 8 cases. Strong immunopositivity was found in
vascular endothelium and fibrous tissue (Fig. 11b).
Carcinoma cells of the cervix seem to loose TNFI and II 
receptors when compared to epithelial cells of the control 
samples
The expression of TNFRI was evaluated in 8 samples of
cervix carcinoma and in 11 samples from controls by
immunohistochemistry. TNFRII was evaluated in 8 sam-
ples of cervix carcinoma and 10 controls (one section
Immunocytochemical staining of TNFRI (a) and TNFR II (b)  of normal keratinocytes Figure 9
Immunocytochemical staining of TNFRI (a) and TNFR II (b) 
of normal keratinocytes.
The effect of histamine and/or TNF-α on SiHa cell migration  in the transwell assay Figure 8
The effect of histamine and/or TNF-α on SiHa cell migration 
in the transwell assay. TNF-α significantly increased the cell 
migration but addition of histamine could not produce any 
additional effect over that by TNF-α alone. The results are 
expressed as the percentage of migrated cells compared to 
those in control wells. (n = 3; mean ± SD). The control is 
indicated as 100%. "*" denotes p < 0.05 when compared with 
control values.
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detached from slide). TNFRI- and TNFRII-positive cells
were semiquantitatively analyzed (Table 1).
In the controls, 8 out of 11 samples displayed immunop-
ositivity with TNFRI located in the basal layers of epider-
mis, whereas one sample showed positivity in the upper
keratinocytes (Table 2). Half of the carcinoma samples
had lost their positivity for TNFRI. TNFRII was shown pos-
itive in the upper layers of epidermis in all control sam-
ples, whereas tumor cells where found negative in two
cases. Interestingly, both negative samples were also neg-
ative for TNFRI (Fig. 12).
Discussion
Previously, histamine has been shown to inhibit the mito-
sis of keratinocytes by utilizing both H1- and H2-recep-
tors [29]. When acting together, histamine and TNF-α
have shown synergism in the induction of ICAM-1 on
normal keratinocytes, an induction which probably
requires H2-receptors [14]. On the other hand, histamine
has been found to induce shedding of TNFRI from the
TNF-α positive cells in the cervix carcinoma – immunohisto- chemical staining of SCC specimens Figure 11
TNF-α positive cells in the cervix carcinoma – immunohisto-
chemical staining of SCC specimens. Note: strong immunop-
ositivity of the epithelial cells of control sample (a); TNF-α 
positive tumor cells and peritumoral stroma in cervix carci-
noma (b).
Immunocytochemical staining of TNFRI (a) and TNFR II (b) in  SiHa SCC cells Figure 10
Immunocytochemical staining of TNFRI (a) and TNFR II (b) in 
SiHa SCC cells.BMC Cancer 2008, 8:46 http://www.biomedcentral.com/1471-2407/8/46
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plasma membrane and mobilization of the receptor from
the Golgi apparatus in endothelial cells, and therefore his-
tamine may transiently inhibit the action of TNF-α
towards the cell [30]. In addition, histamine can suppress
gene expression and synthesis of TNF-α via H2-receptors
in peripheral blood mononuclear cells [31]. Thus, hista-
mine together with TNF-α can induce a range of different
effects on a cell.
In this study, the treatment of normal keratinocytes with
histamine or TNF-α alone resulted in growth inhibition in
a non-cytolytic manner. However, the simultaneous
action of both histamine and TNF-α induced increased
growth inhibition and cytolysis. Therefore, of interest is
the previous finding on normal keratinocytes that the
treatment of keratinocytes with histamine and TNF-α
leads to increased ICAM-1 expression [14] and also to
increased cytolysis. ICAM-1 expression in keratinocytes
not only leads to T cell activation but also to increased
lysis of keratinocytes by cytotoxic T cells [32]. Further-
more, the treatment of cultured keratinocytes with 1 μg/
ml paraphenylenediamine for 3 hours has been found to
induce ICAM-1 expression probably due to slight mem-
brane damage, but 2 μg/ml paraphenylenediamine
induced cytotoxicity [33]. Therefore, it is possible that
during the simultaneous action of histamine and TNF-α,
these mediators first activate and thereby induce ICAM-1
in keratinocytes but further activation causes cytolysis. To
clarify this further, keratinocytes were first cultured with
either histamine or TNF-α, i.e., in conditions which
induce ICAM-1 but not cytotoxicity. After one day, the
medium was changed and TNF-α or histamine, respec-
tively, was added to the culture for one more day. As a
result, increased cytolysis was detected by the MTT assay.
Thus, preactivation of keratinocytes by histamine or TNF-
α renders the cells more susceptible to the subsequent
cytotoxic effects by TNF-α or histamine. Since this mecha-
nism for keratinocyte death in low- and high-calcium con-
ditions appears to be effective, it is possible that it is a
previously unrecognized way for the tissue to control the
growth of the epidermis or epithelium. Heparin binds
efficiently TNF-α and augments the growth inhibition of
TNFRI positive cells in the cervix carcinoma Figure 12
TNFRI positive cells in the cervix carcinoma. (a) – control 
sample; (b) – cervix carcinoma.
Table 1: The presence of TNF-α positive cells in the cervix 
carcinoma and control samples. Score of TNF-α
Score of TNF-α
-++ +
Carcinoma (no. of samples) Tumor 1 6 1
Peritumoral tissue 1 4 2
Control (no. of samples) Epidermis 0 7 3
Upperdermis 0 4 6
Table 2: The presence of TNFRI- and TNFRII-positive cells in the 
cervix carcinoma and control samples
Score of TNFRI Score of TNFRII
++ + - ++ + -
Carcinoma (no. of samples) 1 3 4 1 5 2
Control (no. of samples) 1 8 2 7 4 0BMC Cancer 2008, 8:46 http://www.biomedcentral.com/1471-2407/8/46
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keratinocytes induced by TNF-α [15]. Therefore, the com-
bination of histamine, heparin and TNF-α may be even
more potent for causing keratinocyte death.
TNF-α has controversial effects on cancer cells. It can
cause cytolysis to some cancer cell lines and it has been
used even in clinical trials in the treatment of cancer
patients. On the other hand, it may stimulate cancer cell
growth and therefore anti-TNF-α drugs have been pro-
posed for cancer treatment [3,4]. Further complexity for
the TNF-α effect on cells is caused by HPV viruses in cervi-
cal carcinomas. However, previous in vitro studies indi-
cate that the TNF-α treatment can rather maintain the
growth of cervical carcinoma cells, or even stimulate their
growth in one study, than cause growth inhibition and
cytolysis [5-8]. In order to induce cytolysis in these carci-
noma cells by TNF-α, additional stressors are needed,
such as protein synthesis inhibition or radiation [8,9]. In
addition, the treatment with epidermal growth factor of
ME180S cervical carcinoma cell line has been found to
protect these TNF-α sensitive cells from TNF-α induced
apoptosis [34]. In this study, up to 50 ng/ml TNF-α alone
inhibited only slightly the growth of SiHa cells in a non-
cytolytic manner especially in culture medium depleted
from serum and growth factors. This inhibition can be
attributed to the slight growth arrest at G0/G1 phase of
the cell cycle found in the serum-free medium. Previously,
TNF-α has been found to induce growth arrest at G0/G1
in normal keratinocytes and in HPV-16-immortalized
keratinocytes [15,35]. Instead, no apparent changes in the
cell cycle or mitotic regulatory proteins by TNF-α was
observed in HPV-18-immortalized keratinocytes and in
cervical carcinoma cells, including SiHa and HeLa cell
lines [35]. However, TNF-α has been shown to induce
slight inhibition in the proliferation of human SCC cell
lines from hypopharynx, submaxillary gland, vulva and
esophagus [7].
Previously, chemotactic migration of SiHa and CaSki cer-
vical carcinoma cell lines to laminin-1 has been shown to
be significantly decreased by TNF-α while migration
towards type I collagen was increased [36]. In addition,
TNF-α has a stimulatory effect on the migration of SW756
cervical carcinoma cells [37] and it induces motility of dif-
ferent epithelial tumor cell lines [7]. Thus, the present
finding that TNF-α increased SiHa cell migration towards
serum is in line with these previous findings. Neverthe-
less, TNF-α was not able to induce any apparent increase
in the invasion of SiHa cells through Matrigel™, although
the cells had some capacity to invade in the control wells.
Previously, the invasion capacity of SiHa cells has been
found to be relatively weak through Matrigel™ when com-
pared with that of FaDu and A431 SCC cell lines [38]. The
weak inhibition in the growth and the induction of slight
cell cycle arrest at G0/G1 of SiHa cells by TNF-α were asso-
ciated with increased TNF-α induced SiHa cell migration.
A similar association between growth inhibition and
increased motility has previously been observed in nor-
mal keratinocytes [39] and different epithelial tumor cell
lines [7]. Therefore, even though carcinoma cell prolifera-
tion is slightly inhibited the increased motility of these
cells induced by TNF-α may augment the spread of the
tumor. Nevertheless, the intracellular molecular machin-
ery recruited in these changes by TNF-α needs to be stud-
ied in the future. Furthermore, the spreading carcinoma
cells may have some capability in escaping the immune
surveillance since TNF-α has not been found to induce
ICAM-1 and HLA class 1 and 2 antigens in SiHa and CaSki
cells [40].
Histamine has been suggested to be involved in the regu-
lation of cancer growth since mast cells can typically be
found in increased numbers in the vicinity of tumors
[21,22]. The concentration of histamine within mast cell
secretory granules approximates 100 mM [41], and there-
fore histamine concentrations of up to 100–1,000 μM can
be expected to occur in the microenvironment between
mast cell and cancer cell. However, experimental evidence
clarifying the role of histamine in cervix carcinoma is sur-
prisingly sparse. Previously, histamine at up to 100 μM
concentration has been found to stimulate the growth of
HeLa and A431 SCC cell lines and chemotactic migration
of HeLa cells through the H1 receptor [42]. Also, hista-
mine at up to 100 μM concentration has been shown to
inhibit the production of interferon-induced protein of 10
kDa in SCC15 squamous cell carcinoma line through the
H2 receptor [43]. In this study, histamine at up to 1,000
μM concentration was found to inhibit the growth of
monolayer proliferating keratinocytes as well as the
growth of keratinocyte epithelium, a result which is in line
with our previous findings [44]. In clear contrast to nor-
mal keratinocytes, histamine at 100 or 1000 μM concen-
tration showed no effect on the growth, viability, cell
cycle, migration and invasion of SiHa cells. Only weak
cytotoxicity, if any, by histamine was noted when SiHa
cells were pretreated first with emetine. Thus, histamine
appears to have no marked regulatory role in SiHa cell
growth and motility whereas it may control the growth of
normal epithelium.
Even though normal keratinocytes, grown as monolayer
or epithelium, underwent enhanced growth inhibition
and cytolytic changes when exposed to TNF-α and hista-
mine, no changes in SiHa cell growth, viability, cell cycle,
migration and invasion by TNF-α and histamine were
observed. The pretreatment of SiHa cells with emetine
sensitized the cells to the cytolytic effect of TNF-α, as
expected based on the previous publications [8,10,12].
However, even this additional stressor could not sensitise
SiHa cells to increased cytolysis by the combined action ofBMC Cancer 2008, 8:46 http://www.biomedcentral.com/1471-2407/8/46
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TNF-α and histamine. These results suggest that malig-
nant SiHa cells have lost the capability to respond to this
endogenous cytolytic controlling mechanism by TNF-α
and histamine. The treatment of ME-180 cells with TNF-α
alone resulted in marked growth inhibition in a non-cyto-
lytic manner as expected. However, histamine alone had
no effect. Similarly to SiHa cells, the growth and viability
of ME-180 cells were not affected markedly by the com-
bined action of TNF-α and histamine suggesting that cer-
vix SCC cells are resistant to this cytolytic mechanism.
The effect of TNF-α is mediated to the cell via TNFRI and
TNFRII receptors. The intracellular signal mechanisms are,
however, complex since TNFR ligation can activate differ-
ent signalling routes [4]. In this study, we chose to stain
TNFRI and II immunocytochemically directly on chamber
slides since proteolytic detachment of cells may cleave cell
membrane structures and receptors. However, the disad-
vantage is that the method is rather semiquantitative and
it may be difficult to clearly demonstrate weak TNFR
staining. Nevertheless, both TNFRI and II immunoreactiv-
ities were markedly expressed in normal keratinocytes and
therefore these cells can be supposed to respond to TNF-α
in a normal fashion. Instead, untreated SiHa and ME-180
cells displayed only weak immunoreactivity of TNFRI and
II and only some occasional cells appeared to clearly dis-
play these receptors. This clear difference may provide one
explanation that normal keratinocytes respond to TNF-α
and histamine in a cytolytic fashion whereas SiHa and
ME-180 cells do not. However, additional investigation is
needed to clarify this difference.
Previously, tumor cells of SCC from head and neck as well
as from oral cavity have been shown to contain the immu-
noreactivity of TNF-α and TNFRI and II [25,26]. In addi-
tion, cervix carcinoma and SiHa cells have been shown to
express TNF mRNA [45]. Since SiHa cells showed only
weak TNFRI and II immunostaining these receptors as
well as TNF-α were stained also in cervical carcinoma
specimens. Cervix specimens showing non-specific
inflammatory changes were chosen as controls since
inflammation is a typical feature of cancers, too. However,
these sample groups are not directly comparable. Never-
theless, only one cervix carcinoma specimen out of 8
revealed marked TNFRI or TNFRII immunopositivity. The
same sample was also highly positive by TNF-α staining.
In control samples, TNFRI showed slight positivity in 8
out of 11 cases, one case being strongly positive. For
TNFRII, 7 cases were found strongly positive, whereas 4
were weakly positive. There were large areas among tumor
cell sites showing no apparent staining of these receptors.
Thus, it appears that cervix carcinoma cells contain less
receptors TNFRI and TNFRII when compared with the epi-
thelium in samples with non-specific inflammation.
Interestingly, a significant inverse correlation has been
found between the expression intensity of 55-kDa TNFR
and the velocity of tumor growth of oral SCC [25]. The
peritumoral stroma contained TNF-α positive cells
though the score for the subepithelial stroma of control
specimens tended to be higher. However, both the carci-
noma cells and control epithelial cells were immunos-
tained in a similar intensity for TNF-α. Hence, TNF-α is
present at least in some quantities in most of the carci-
noma tissue specimens.
Conclusion
In conclusion, the combination of TNF-α and histamine
has a profound growth-inhibitory and cytolytic effect on
normal keratinocytes. Instead, this combination showed
no significant effect on the growth, viability, cell cycle,
migration and invasion of SiHa cells suggesting that these
cells have lost their capability to respond to this endog-
enous cytolytic mechanism, possibly owing to their lower
TNFRI and TNFRII expression. Likewise, another SCC cell
line, ME-180 was also resistant to the combined action of
TNF-α and histamine. TNF-α alone induced slight growth
inhibition and cell cycle arrest at G0/G1 phase in serum-
free medium and increased the migration of SiHa cells.
Since TNF-α was found to be present in the cervix carci-
noma tissue it may have the capability to promote the
spread of carcinoma cells. However, the expression level
of TNFRI and TNFRII in the tumor cells of cervix carci-
noma may not be sufficient for allowing cytolytic changes
induced by TNF-α.
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